Tin tức & Cập nhật
Xem bài viết Ung thư
Xem

Tucatinib-T-DM1 combo improves PFS in patients with metastatic breast cancer
Treatment with trastuzumab emtansine (T-DM1) plus tucatinib safely prolongs progression-free survival (PFS) in patients with previously treated HER2-positive locally advanced (LA) or metastatic breast cancer (MBC), including those with brain metastases, reports a study.

Better sleep yields greater weight loss for breast cancer survivors
Breast cancer survivors who have adequate sleep achieve greater benefits from behavioural weight loss (BWL) intervention than those with poor sleep, according to the results from the POWER-Remote trial.

Lung cancer screening necessary for at-risk non-smokers
Never smokers with selected risk factors who undergo lung cancer screening may show similar detection rates to high-risk ever smokers or even higher rates when compared with unselected never smokers, reveals a Singapore study.

Could melatonin help with hot flushes in prostate cancer patients on ADT?
A randomized, double-blind, placebo-controlled trial from Iran reports a significant reduction in frequency of mild hot flushes with use of melatonin in patients with prostate cancer (PC) undergoing androgen deprivation therapy (ADT).





